Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00611949 · ClinicalTrials.gov registry record · NA
Comparison of 2 Vials of Components of a Synthetic Geranium Oil
A NA study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT00611949: Completed NA study, sponsored by Pennington Biomedical Research Center.
NCT00611949 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 64 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00611949, a NA study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The purpose of this study is to determine which component of an artificial geranium oil helps to reduce your neuropathy pain.
Interventions
- OTHER Geranium oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2002-05 |
| Est. Completion | 2011-12 |
| Phase | NA |
What the finished NCT00611949 record still lists
NCT00611949 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Geranium oil is the first listed.
NCT00611949 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00611949 about?
NCT00611949 is a clinical study titled "Comparison of 2 Vials of Components of a Synthetic Geranium Oil". The purpose of this study is to determine which component of an artificial geranium oil helps to reduce your neuropathy pain.
What is the current status of trial NCT00611949?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2002-05. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00611949?
The interventions under investigation include: Geranium oil (OTHER).
Who is sponsoring clinical trial NCT00611949?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00611949's enrollment target sits among peer trials
64 1147th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia